A Phase II Study of Neoadjuvant Tislelizumab and Axitinib in Patients with Locally Advanced Non-Metastatic Clear Cell Renal Cell Carcinoma (Accrcc).

Ritesh R. Kotecha,Sahil D. Doshi,Andrea Knezevic, Rachel Jacobi,David H. Aggen,Deaglan Joseph McHugh,Neil J. Shah,Marie Isabel Carlo,Niamh M. Keegan, Yogini Gayadin,Joshua Chaim,Darren R. Feldman,Robert J. Motzer,Martin H. Voss

Journal of Clinical Oncology（2024）

Cited 0|Views8

Key words

261-3278,283-424-3231-2482,3282-3306-7927-3999,261-492-2769,298-145-222-184-4809-5347,261-492-5651-9270-5652,261-492-3532-2370-7650-2700,2424,319,319,2424,38092-29187,38092-20390,38092-20072

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined